Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

Phase 3CompletedNCT04674332

Ain Shams University148 enrolled

Overview

multiple dose regimen as a standard treatment for gestational diabetes will be compared to long acting insulin

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

148

Conditions

Long Acting Insulin in Control of Gestational Diabetes Mellitus

Interventions

Long acting insulinDRUG

long acting insulin analogue once daily at bed time

multiple dose regimenDRUG

intermediate and short acting insulin

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * pregnant women with gestational diabetes mellitus * between 24-28 weeks gestation Exclusion Criteria: * other endocrinological abnormalities

Locations (1)

Ain Shams University Maternity Hospital

Cairo, Egypt

Outcomes

Primary Outcomes

time needed to achieve glycemic control

glycemic control assessed by fasting and postprandial blood sugar

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.